Atlas Trials

New Double Epigenetic Regimen in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Clinical trial NCT05029141 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05029141
Sponsor
The First Affiliated Hospital of Soochow University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Myeloid LeukemiaRefractory Acute LeukemiaRelapsed Adult AML
Start date
2021-09-01
Primary completion
2026-12-31
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.